Clinical trial

In collaboration with the World Health Organization, the University Hospitals of Geneva (HUG) are conducting a phase 1 trial to test the safety of the Ebola vaccine VSV-ZEBOV and its ability to trigger an immune response in healthy adult volunteers.


logo Recherche

A center for emerging viruses

Emerging viruses: these words evoke elusive enemies and uncontrollable health crises. An unknown disease hits a corner of the world and has repercussions on global health. Like H5N1or MERS several years ago, Ebola in 2015 and Zika in 2016.